Steve Jolley, CEO

• 27 years' experience in drug safety & pharmacovigilance
• Specialist in global safety compliance, business process improvement and signal detection
• Worked with over 100 clients in the US, Europe, Japan, India, and China
• Featured speaker with FDA and MHRA at DIA conferences and webinars on drug safety topics including auditing and signaling
• Chairperson of the DIA Clinical Safety and Pharmacovigilance steering committee for North America
• Degrees in mathematics and computer science from Cambridge University, England